Conditions

156 conditions for which we help patients access specialty medicines via cross-border NPP.

Cardiology

Familial Hypercholesterolemia Heart Failure Hypertrophic Cardiomyopathy Pulmonary Arterial Hypertension Transthyretin Amyloidosis

Dermatology

Alopecia Areata Atopic Dermatitis Hidradenitis Suppurativa Psoriasis Vitiligo

Endocrinology

Acromegaly Congenital Adrenal Hyperplasia Cushing's Syndrome Hypophosphatasia Obesity Osteoporosis Type 1 Diabetes Type 2 Diabetes X-linked Hypophosphatemia

Gastroenterology

Crohn's Disease Eosinophilic Esophagitis Eosinophilic Gastroenteritis Short Bowel Syndrome Ulcerative Colitis

Hematology

Aplastic Anemia Hemophilia A Hemophilia B ITP Myelodysplastic Syndrome Myelofibrosis Paroxysmal Nocturnal Hemoglobinuria Polycythemia Vera Sickle Cell Disease Thalassemia von Willebrand Disease

Hepatology

NASH Primary Biliary Cholangitis Primary Sclerosing Cholangitis

Immunology

ANCA-Associated Vasculitis Ankylosing Spondylitis Behçet Disease Chronic Granulomatous Disease Chronic Spontaneous Urticaria Common Variable Immune Deficiency Cryopyrin-Associated Periodic Syndrome Familial Mediterranean Fever Giant Cell Arteritis Hereditary Angioedema Muckle-Wells Syndrome Psoriatic Arthritis Rheumatoid Arthritis SCID Still's Disease Systemic Lupus Erythematosus Takayasu Arteritis

Infectious Disease

Cytomegalovirus Infection HIV Hepatitis B Hepatitis C Invasive Fungal Infections Tuberculosis

Metabolic

Alkaptonuria Cystinosis Fabry Disease Gaucher Disease Homocystinuria Krabbe Disease Lysosomal Acid Lipase Deficiency MPS I (Hurler)MPS II (Hunter)MPS III (Sanfilippo)MPS VI (Maroteaux-Lamy)Niemann-Pick Disease PKU (Phenylketonuria)Pompe Disease Tay-Sachs Disease Urea Cycle Disorders Wilson Disease

Nephrology

C3 Glomerulopathy Chronic Kidney Disease Focal Segmental Glomerulosclerosis IgA Nephropathy

Neurology

Alzheimer's Disease Amyotrophic Lateral Sclerosis Angelman Syndrome Autoimmune Encephalitis Batten Disease CDKL5 Deficiency Disorder CIDP Chronic Inflammatory Demyelinating Polyneuropathy Chronic Migraine Dravet Syndrome Epilepsy Fragile X Syndrome Friedreich Ataxia Guillain-Barré Syndrome Huntington's Disease Lennox-Gastaut Syndrome Metachromatic Leukodystrophy Multiple Sclerosis Myasthenia Gravis NMO Spectrum Disorder Narcolepsy Parkinson's Disease Progressive Supranuclear Palsy Restless Legs Syndrome Rett Syndrome Stiff Person Syndrome Tuberous Sclerosis Complex

Neuromuscular

Duchenne Muscular Dystrophy Spinal Muscular Atrophy

Oncology

Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Bladder Cancer Breast Cancer Chronic Lymphocytic Leukemia Chronic Myeloid Leukemia Colorectal Cancer Endometrial Cancer Gastric Cancer Glioblastoma Head and Neck Cancer Hepatocellular Carcinoma Hodgkin Lymphoma Lung Cancer (NSCLC)Melanoma Multiple Myeloma Non-Hodgkin Lymphoma Ovarian Cancer Pancreatic Cancer Prostate Cancer Renal Cell Carcinoma Thyroid Cancer

Ophthalmology

Diabetic Retinopathy Geographic Atrophy Glaucoma Keratoconus Leber Congenital Amaurosis Neurotrophic Keratitis Retinitis Pigmentosa Stargardt Disease Uveitis Wet AMD

Otolaryngology

Chronic Rhinosinusitis Nasal Polyps

Pediatrics

Kawasaki Disease

Psychiatry

ADHD Autism Spectrum Disorder Bipolar Disorder Major Depressive Disorder Schizophrenia Treatment-Resistant Depression

Pulmonology

COPD Cystic Fibrosis Idiopathic Pulmonary Fibrosis Severe Asthma

AI disclosure & medical review. Content on this page is reviewed by Reserve Meds's AI Pharmacist and AI Regulatory Counsel. A US-licensed human pharmacist (dispensed by Altima Care, license: Pending issuance) reviews every prescription before dispensing. Regulatory posture is AI-summarized and not legal advice; case-specific questions route to retained outside counsel. Last medically reviewed: 2026-04-22.